Title of article :
Comments on “The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and
Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and
3”
Author/Authors :
Sayad Babak نويسنده , Farokhi Alireza نويسنده Liver Diseases Research Center, Kermanshah University of
Medical Sciences, Kermanshah, Iran , Norooznezhad Fatemeh نويسنده Liver Diseases Research Center, Kermanshah University of
Medical Sciences, Iran
